Hepatocellular carcinoma: Impact of waiting list and pre-operative treatment strategies on survival of cadaveric liver transplantation in pre-MELD era in one center in Brazil;Carcinoma hepatocelular: Impacto do tempo em lista e das formas de tratamento pré-operatório na sobrevida do transplante de fígado cadavérico na era pré-MELD em um centro no Brasil

Arquivos de Gastroenterologia

Volumn 44, Issue 3, 2007, Pages 189-194

  De Freitas, Alexandre Coutinho Teixeira ^a,b   Parolin, Mônica Beatriz ^a   Stadnik, Lucinei ^a   Coelho, Júlio Cezar Uili ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b NONE   (Brazil)

Author keywords

Carcinoma, hepatocellular; Liver cirrhosis; Liver transplantation; Survival analysis

Indexed keywords

ADULT; ARTICLE; BRAZIL; CADAVER DONOR; ERYTHROCYTE TRANSFUSION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PREOPERATIVE TREATMENT; SCORING SYSTEM; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; UNIVERSITY HOSPITAL;

EID: 36849006933     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/s0004-28032007000300002     Document Type: Article

References (21)

1. Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 1999;19:311-22.
2. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, Visa J, Bru C, Rodes J. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996;111:1018-22.
3. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lenciono R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J, EASL Panel of Experts of HCC. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL Conference. J Hepatol. 2001;35:421-30.
4. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745-50.
5. Habib S, Berk b, Chang CH, Demetris AJ, Fontes P, Dvorchik I, Eghtesad B, Marcos A, Shakil AO. MELD and prediction of post-liver transplantation survival. Liver Transplant. 2006;12:440-7.
6. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H, Kawanishi M. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 1993;18:47-53.
7. Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, Tzakis AG, Van Thiel DH, Carr B, Selby R, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg. 1991;214:221-8.
8. Jonas S, Bechstein WO, Steinmuller T, Hermann M, Radke C, Berg T, Settmacher U, Neuhaus P. Vascular invasion and histolopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology. 2001;33:1080-6.
9. Kanwal F, Dulai GS, Spiegel BM, Yee HF, Gralnek IM. A comparison of liver transplantation outcomes in the pre- vs Post-MELD eras. Aliment Pharmacol Ther. 2005;21:169-77.
10. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;39:1434-40.
11. Llovet JM, Burroughs A, Bruix J. Hepatocellular Carcinoma. Lancet 2003;362:1907-17.
12. Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat I, Perrin H, Azoulay D. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg. 1997;226:688-701.
13. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med. 1996;334:693-9.
14. Mor E, Kaspa RT, Sheiner P, Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med. 1998;129:643-53.
15. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, Onishi K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985;56:918-28.
16. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992;15:948-63.
17. Registro Brasileiro de Transplantes. 2005;11(2) Disponível em http://www.abto.org.br
18. Ringe B, Pichlmayr R, Wittekind C, Tursch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg. 1991:15:270-85.
19. Shah SA, Tan JC, McGilvray ID, Cattral MS, Cleary SP, Levy GA, Greig PD, Grant DR. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation 2006;81:1633-9.
20. United Network for Organ Sharing. 2005 Annual report of the U.S. scientific registry for transplant recipients and the organ procurement and transplantation network. Available at: www.optn.org.
21. Yoo HY, Thuluvath PJ. Short-term post liver transplant survival after the introduction of MELD scores for organ allocation in the United States. Liver Int. 2005;25:536-41.